Supplementary Figure S1 from Tumor-Informed ctDNA Assay to Predict Outcome in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with PD-1 Inhibitor

Supplementary Figure S1 from Tumor-Informed ctDNA Assay to Predict Outcome in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with PD-1 Inhibitor

<p>Relationship between ctDNA kinetics and best overall response (BOR) stratified by immune checkpoint inhibitor type. Stacked bar plots illustrating the distribution of best overall response (BOR: complete response [CR], partial response [PR], stable disease [SD], and progressive disease [PD]...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autore principale: Natasha Honoré (22618729) (author)
Altri autori: George Laliotis (17534845) (author), Vasily N. Aushev (22618732) (author), Sharlene Velichko (22348624) (author), Charuta C. Palsuledesai (22618735) (author), Hajar Dahou (22618738) (author), Cédric van Marcke (22618741) (author), Rachel Galot (20852640) (author), Minetta C. Liu (15032247) (author), Jean-Pascal Machiels (18366157) (author)
Pubblicazione: 2025
Soggetti:
Cancer
Cancer Detection and Diagnosis
Immuno-oncology
Biomarkers
Circulating tumor cells/DNA/exosomes
Prognostic biomarkers
Head, Neck & Oral Cancers
Immunotherapy
Biomarkers for immunotherapy
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi